(9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class ...
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.
If you're shopping for a tween or teen this holiday season, chances are they have at least one item on their wish list that could cause hearing loss if used inappropriately.
Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new data at the 2025 San Antonio Breast ...
The authoritative neuroradiology reference Diagnostic Imaging: Brain, Fifth Edition (Elsevier) now confirms that functional neuroimaging tools like SPECT can detect Chronic Traumatic Encephalopathy ...
United Breast Cancer Foundation (UBCF) proudly announces the success of its multi-day, holiday themed Pink Bag Event, held ...
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...
Kenosha-based center offering complimentary mental health treatments for firefighters KENOSHA, Wis., Dec. 11, 2025 /PRNewswire/ -- Empower & Wellness Clinic is offering complimentary mental health ...
Non-invasive saliva testing reveals insulin levels that indicate metabolic health risks including Type 2 diabetes and obesity. Medindia's policies are aligned with the United Nations Sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback